project id: TCGA-UCEC; case submitter id: TCGA-AJ-A2QM; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 9.2; age at index: 67; days to birth: -24776; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1944; age at diagnosis: 24776; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 894.0; figo stage: Stage II; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: Not Reported; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 108; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-AJ-A2QM-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 8.0; percent necrosis: 4.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 86.0; percent tumor nuclei: 90.0;